Alexion's Soliris Approved in Japan for Patients with aHUS

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ), today announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan has approved the use of Soliris® (eculizumab) for the treatment of pediatric and adult